Cargando…
Limited HIV-1 Reactivation in Resting CD4(+) T cells from Aviremic Patients under Protease Inhibitors
A latent viral reservoir that resides in resting CD4(+) T cells represents a major barrier for eradication of HIV infection. We test here the impact of HIV protease inhibitor (PI) based combination anti-retroviral therapy (cART) over nonnucleoside reverse transcriptase inhibitor (NNRTI)-based cART o...
Autores principales: | Kumar, Amit, Abbas, Wasim, Bouchat, Sophie, Gatot, Jean-Stéphane, Pasquereau, Sébastien, Kabeya, Kabamba, Clumeck, Nathan, De Wit, Stéphane, Van Lint, Carine, Herbein, Georges |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138822/ https://www.ncbi.nlm.nih.gov/pubmed/27922055 http://dx.doi.org/10.1038/srep38313 |
Ejemplares similares
-
Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line
por: Kumar, Amit, et al.
Publicado: (2016) -
Counteracting Akt Activation by HIV Protease Inhibitors in Monocytes/Macrophages
por: Pasquereau, Sébastien, et al.
Publicado: (2018) -
Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1
por: Bouchat, Sophie, et al.
Publicado: (2015) -
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression
por: Darcis, Gilles, et al.
Publicado: (2015) -
Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection
por: Reuse, Sophie, et al.
Publicado: (2009)